Back to search

National and Kapodistrian University of Athens

Μελέτη των αναστολέων των μεταλλοπρωτεϊνασών στην αθηρωμάτωση

Abstract

dc:description

Introduction: Atherosclerosis is a disease of the arterial wall with high levels ofmorbidity and mortality. Modern therapeutic interventions aim towards both theattenuation of the lumen stenosis as well as the stabilization of the atheromatousplaque and the avoidance of its rupture, which is the cause of the majority ofcardiovascular events. The unstable plaque can be identified by its thin fibrous cap, alesser amount of extracellular connective proteins (collagen and elastin) and extensiveinflammation. The cleavage of collagen and elastin weakens the atheromatous plaque,and is mediated by specific proteolytic molecules, the matrix metalloproteinases(MMPs), which are mostly produced by inflammatory cells (macrophages, foam cells)and the Smooth Muscle Cells within the atheroma. Accumulating evidence pointtowards the fact that the MMPs and their tissue inhibitors (TIMPs) are involved in adelicate balance, which in great part defines the clinical outcome of the disease.Statins, that are proven to exert atheroprotective role through their effect ondecreasing cholesterol blood levels, are thought to have additional atheroprotectivemechanisms through the modification of signaling pathways that control theinflammatory process and influence the MMP and TIMP expression and function.Systematic, long term exercise is known to positively contribute in the attenuation ofcardiovascular disease. The modification of the traditional cardiovascular risk factorsthrough exercise, can only in part explain its’ atherosclerosis ameliorating results,leading scientists to search for additional atheroprotective actions of exercise. Amongothers, the modification of MMP and TIMP expression and function are considered.Aim: Subject of the present study was to investigate the effects of two antiatherosclerotictherapeutic strategies, that of atorvastatin treatment and of systematicexercise, as well as their combined effects on the MMP and TIMP function, inconjunction with the atheromatous plaques’ size and stability.Experimental design: Prospective, randomized, controlled, interventional study.Setting: Center of Experimental Surgery, Foundation of Biomedical Research,Academy of Athens.Subjects: Male ApoE-/- C57BL/6J knockout mice.Methods: At the age of 8 weeks, mice were randomized in the following groups: a)Control group (CO, n=10), b) Atorvastatin treatment group (AT, n=10), c) Exercisetreatment group (EX, n=10), d) Combined atorvastatin and exercise treatment group (AT+EX, n=10). All groups were fed atherogenic, “western type” high-fat diet for thewhole study duration (24 weeks). At the beginning of the 16th week the all groupsbesides CO began receiving the predefined therapeutic intervention. Atorvastatin(10mg/kg) was administered in group AT daily for the rest of the study duration(8weeks). Group EX underwent an exercise program on a motorized treadmill(8weeks, 5days/week, 40min/session, 12m/min, 5o inclination). Group AT+EXreceived atorvastatin treatment similar to group AT, and concurrently underwent thesame exercise program as group EX. At the end of the study all mice were sacrificed.The aortic arch was removed and was further processed for paraffin embedding andoptical microscopy sectioning, while the thoracic aorta was deep frozen for lateranalysis. The area of the lumen cross-section and that of the atheromatous plaqueswas measured histochemically, and the lumen stenosis factor was calculated.Additionally, the positive stain ratio of the plaques for collagen, elastin, macrophages,smooth muscle cells, ΜΜΡ-2, ΜΜΡ-3, ΜΜΡ-8, ΜΜΡ-9, ΤΙΜΡ-1, ΤΙΜΡ-2 andTIMP-3 was measured, by means of histochemical and immunohistochemical methods. Blood samples were acquired from all mice at the beginning of the study,after the atherosclerosis establishment (16th week) and at the study’s end. Blood levelsof total cholesterol, glucose, and triglycerides were determined as well as theconcentrations of ΜΜΡ-2, ΜΜΡ-3, ΜΜΡ-8, MMP-9, ΤΙΜΡ-1, TIMP-2 and TIMP-3.The thoracic aorta sections were zymographically analyzed for the determination ofMMP-2, MMP-9, TIMP-1 and TIMP-2 activity.Results: Both therapeutic interventions attenuated atherosclerosis development. Thiswas evident in the lower extent of the atheromatic lesions in the ΑΤ group, and in thelower degree of lumen stenosis in all intervention groups. Furthermore, thetherapeutic modalities acted in synergy, achieving significantly better results in thecombined intervention group. All interventions failed to differentiate the experimentalgroups regarding weight loss and blood glucose, while only the atorvastatinadministration modestly reduced blood lipids. Atheromatous plaques showed a morestable phenotype in the intervention groups, containing more collagen and elastin,with elastin being further increased in the AT+EX group. These changes wereaccompanied by a favorable modification of MMP-3, MMP-8 and MMP-9. MMP-8function was closely associated with collagen levels, while the reduction in MMP-9prevalence and function was loosely related to the elevated levels of elastin.Therepautic interventions did not affect the smooth muscle cell content of the lesions, but did reduce the presence of macrophages in the athromatous plaques, but thecombined intervention did not confer additional changes. Exercise treatment increasedTIMP-1 levels, and subsequently reduced the net proteolytic activity within theplaque. On the contrary, TIMP-2 was decreased in all intervention groups and TIMP-3 appeared unaffected. While the blood levels of the above molecules increasedduring atherosclerosis development in comparison with baseline measurements (withthe exception of TIMP-3), they did not change after the therapeutic interventions inaccordance to their intra-plaque levels. Active MMP-2 was reduced after atorvastatinadministration, increased after exercise treatment and exhibited unchanged levels afterthe combined interventions. Its proenzyme expression though, was reduced after allinterventions.Conclusions: The two therapeutic strategies act with synergy regarding the extent ofthe atheromatic lesions and lumen stenosis. Moreover, they stabilize the plaque byincreasing its content in elastin and collagen, which is achieved mainly by theirinfluence on MMP and TIMP levels. The increased elastin levels are attributed ingreat part in the modification of MMP-2/TIMP-2 balance and in the MMP-9 levels reduction that is achieved through the lower extent of macrophage prevalence insidethe plaque. MMP-8 concentration in the lesion area is correlated with the pattern ofcollagen preservation. The effects of both atorvastatin and exercise on the MMP andTIMP levels are mainly associated with the macrophage amount and type, and not inchanges regarding smooth muscle cells. The increased MMP-2, MMP-3, MMP-8 andMMP-9, as well as TIMP-1 and TIMP-2 (but not TIMP-3) blood concentration is amarker of atherosclerosis. On the other hand, blood levels of MMP-2, MMP-3 andMMP-8 are not correlated with their concentration within the atheromatous plaqueafter the therapeutic interventions, and therefore cannot serve as markers of thedisease development or amelioration.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Moustardas, Petros
  • Μουστάρδας, Πέτρος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41463

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Moustardas, Petros; Μουστάρδας, Πέτρος. Μελέτη των αναστολέων των μεταλλοπρωτεϊνασών στην αθηρωμάτωση. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/41463